title: Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator.
authors.affiliation: Department of Neurology, University of Cincinnati Neuroscience Institute, 260 Stetson St, Suite 2300, PO Box 670525, Cincinnati, OH 45267-0525, USA. joseph.broderick@uc.edu
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Broderick
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Tomsick
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D012051:Reimbursement Mechanisms; D020521:Stroke / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D017131:Thrombectomy / Q000191:economics* / Q000295:instrumentation; D015912:Thrombolytic Therapy / Q000191:economics* / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator